Clinical Trial Update: A Phase 1/2A Study of LAM561 in Adult Patients With Advanced Solid Tumours [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2A study update for LAM561 in adults with advanced solid tumours has completed enrollment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma
• Other Solid Tumours

Drugs mentioned

• LAM561 (LAM561)

Snippet

Sponsor: Laminar Pharmaceuticals | Conditions: Glioma, Other Solid Tumours | Phase 1, Phase 2 | Status: COMPLETED